Singapore Diagnostics (SGD) triumphed at the Healthcare Asia Awards 2025, held on April 10, winning three prestigious awards. The company was named Diagnostics Provider of the Year for the third consecutive time, along with winning Facilities Improvement Initiative of the Year and ICT Initiative of the Year.

Singapore Diagnostics (SGD), the Philippine flagship of Singapore-based Pathology Asia, has been recognized as a consistent healthcare leader, earning eight major national and regional awards from 2023 to 2025. These accolades highlight the company’s commitment to innovation, quality service, and affordable diagnostics for Filipinos.

Singapore Diagnostics (SGD) won the ICT Initiative of the Year at the Healthcare Asia Awards 2025 for its innovative e-SLIP platform. The award highlights SGD’s leadership in healthcare technology and its commitment to improving laboratory integration across the Philippines.